Market Cap

$121.3B

Volume

1.2M

Cash and Equivalents

$9.2B

EBITDA

$4.6B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$5.6B

Profit Margin

55.35%

52 Week High

$471.39

52 Week Low

$323.02

Dividend

N/A

Price / Book Value

6.55

Price / Earnings

30.51

Price / Tangible Book Value

7.31

Enterprise Value

$107.5B

Enterprise Value / EBITDA

23.21

Operating Income

$4.4B

Return on Equity

24.38%

Return on Assets

12.82

Cash and Short Term Investments

$10.2B

Debt

$721.3M

Equity

$18.5B

Revenue

$10.2B

Unlevered FCF

$3.3B

Sector

Biotechnology

Category

N/A